200,000 square feet of automated glass greenhouses

Alliance Growers to build greenhouses at botany centre

2018-03-05 06:30 ET - News Release

Mr. Dennis Petke reports

ALLIANCE GROWERS REPORTS STATE-OF-THE-ART GREENHOUSES AND PROPRIETARY CBD STRAIN
Alliance Growers Corp. will add state-of-the-art greenhouses for year-round nurseries of cannabis plants for the production of a propriety cannabinoid strain at the company's cannabis botany centre. The initial rollout plans for up to 200,000 square feet of automated glass greenhouses with P.L. high-end horticultural lighting. The Alliance Growers' greenhouses will be capable of producing over 300,000 grams per week or 15,600 kilograms per year of dried CBD cannabis.

In a news release dated Dec. 30, 2017, Alliance Growers announced that it has entered into a binding letter of intent with WFS Pharmagreen Inc., and its proposed subsidiary BC New Co,, to create a strategic relationship, together with equity participation by Alliance and Pharmagreen, whereby Alliance will acquire a 30-per-cent equity interest in Pharmagreen's subsidiary BC New Co. The execution of this LOI initiated the development of the cannabis botany centre that Alliance and Pharmagreen have been working on for the past year.

The state-of-the-art greenhouses will be a new addition to the cannabis botany centre in Deroche, B.C. (located 1.5 hours east of Vancouver). The land is a 25-acre property, where the plus-40,000-square-foot cannabis botany centre is being built to permit the growth and sale of tissue culture plantlets, and storage of strains and nursery plants to wholesale, retail and medical markets. The land will now include the state-of-the-art greenhouses for year-round nurseries of cannabis plants as well as to produce its propriety CBD strain, named CBD Dana. With a tested content of plus 10 per cent CBD and THC of less than 0.3 per cent, CBD Dana is a unique strain with its high CBD and low THC content. This makes it ideal for cultivation as an industrial hemp plant label, and therefore an optimal strain for industrial hemp farming. This strain will be one of the flagship strains for CBD hemp farming and the female plantlets produced in the tissue culture lab within the cannabis botany centre will be available for hemp farmers on a global scale. Providing hemp farmers all female, fully rooted plantlets, of CBD Dana will provide a significant yield in CBD production for hemp farmers. This is because the content is 1,000 times or higher than traditional hemp strains with 1-per-cent-CBD content. Additional increase in the CBD yields is achieved when no males are present to pollinate the females which increases the flower content by an additional 80 per cent. The cannabinoids are mainly produced in the flower portion of the female plant, therefore planting female plantlets instead of planting from seed eliminates the males and keeps the flower production at maximum.

Commenting on the addition of the state-of-the-art greenhouses and the production of the proprietary CBD strain, Dennis Petke, Alliance Growers' president and chief executive officer, trumpeted: "We are fortunate to be associated with Pharmagreen to benefit from this opportunity with the addition of the state-of-the-art greenhouses that will provide the flower to make it possible to produce a proprietary CBD strain as we forge ahead with the rapid development and continuing expansion of the cannabis botany centre. These developments will add both breadth and depth to Alliance Growers' global diversification and complement the company's strategy of building a global cannabis company for where the market is going not where the market is today."

About Alliance Growers Corp.
Alliance Growers is a diversified cannabis company driven by the company's four-pillar organization plan -- cannabis botany centre, strategic ACMPR (Access to Cannabis for Medical Purposes Regulations) investments, CBD oil supply and distribution, and research and development.

Antibe Therapeutics confirms timing of ATB-346 trial

2018-02-26 10:10 ET - News Release

Mr. Dan Legault reports
ANTIBE THERAPEUTICS PROVIDES UPDATE ON PHASE 2B GASTROINTESTINAL SAFETY STUDY OF LEAD PAIN DRUG, ATB-346
Antibe Therapeutics Inc. would like to confirm the previously announced timing for its phase 2B double-blind clinical trial of ATB-346. The final subject has now completed treatment and the subsequent two-week monitoring period. The contract research organization conducting the study, Topstone Research Inc. ("Topstone"), is currently performing data validation and analysis. Antibe remains on its previously announced schedule and anticipates being in a position to report top-line results during the week of March 19th, 2018.

The study was conducted in 240 healthy volunteers and is designed to demonstrate the unequivocal superiority of ATB-346 in gastrointestinal ("GI") safety compared to naproxen, the most prescribed nonsteroidal anti-inflammatory drug ("NSAID") in the USA.

About ATB-346
ATB-346 is a hydrogen sulfide-releasing derivative of naproxen. NSAIDs are the most commonly used therapy for osteoarthritis, yet their use is associated with a high incidence of gastrointestinal ulceration and bleeding. NSAIDs are also widely used in a number of conditions, including rheumatoid arthritis, ankylosing spondylitis, and general pain reduction, with a similarly high rate of gastrointestinal ulceration and bleeding. It is well-accepted that patients with these conditions would benefit greatly from an effective, GI-sparing anti-inflammatory/analgesic agent such as ATB-346.

About Antibe Therapeutics Inc.
Antibe develops safer medicines for pain and inflammation. Antibe's technology involves linking a hydrogen sulfide-releasing molecule to an existing drug to produce a patented, improved medicine. Antibe's lead drug ATB-346 targets the global need for a safer, non-addictive drug for chronic pain and inflammation. ATB-352, the second drug in Antibe's pipeline, targets the urgent global need for a non-addictive analgesic for treating severe acute pain, while ATB-340 is a GI-safe derivative of aspirin. www.antibethera.com.

Antibe's subsidiary, Citagenix Inc. ("Citagenix"), is a leader in the sales and marketing of tissue regenerative products servicing the orthopedic and dental marketplaces. Since its inception in 1997, Citagenix has become an important source of knowledge and experience for bone regeneration in the Canadian medical device industry. Citagenix is active in 15 countries, operating in Canada through its direct sales teams, and internationally via a network of distributor partnerships. www.citagenix.com.
We seek Safe Harbor.

Alliance Growers to Acquire Quebec Late Stage ACMPR Applicant

 

Vancouver, British Columbia--(Newsfile Corp. - February 21, 2018) - Alliance Growers Corp. (CSE: ACG) (FSE: 1LA) (WKN: A2DFYX) ("Alliance Growers" or the "Company") is pleased to report that it has entered into an exclusive agreement to acquire a late stage licensed producer applicant, Biotech Canna, to become a licensed producer under Health Canada's access to cannabis for medical purposes regulations ("ACMPR") in Quebec. Alliance Growers will supply financing and resources to build out the medical marijuana facility in preparation for the inspection required to obtain a growing license. Once Health Canada is satisfied with a successful crop, Alliance Growers will be granted its distribution license.

This is a key acquisition for Alliance Growers and its shareholders, as it allows the company an opportunity to become a licensed producer in the province of Quebec and gain an in-road to provide tissue culture plantlets to all licensed producers in Quebec.

There are several key points of value that are unique and advantageous to a Quebec license that include:
- 20% of Canada population is in Quebec
- Only 2 licenses have been approved in Quebec with only 1 producing (Hydropocathary).
- Quebec government has always looked to attain 25% of whatever Canada's intentions are with business. They have publicly stated they want Health Canada to process all the licenses- 16 Applications - in Quebec and have the applications approved swiftly.
- Quebec will only purchase the supply from Quebec growers, they won't go outside to other provinces for supply if they don't need to.

The initial Biotech Canna facility is 10,000 sq. ft. and is attached to a 120,000-sq. ft. warehouse for expansion. Biotech Canna will produce up to 1,000 kg per year and will increase that output in Phase 2 of expansion".

Alliance Growers is making an initial payment of $100,000 and $150,000 in stock. Alliance Growers will acquire 100% of the Quebec late stage licensed producer applicant in stages for a total consideration of $8 Million - cash consideration of $600,000 and $7.4 Million in stock at a deemed value of $1/share, the final payment of $500,000 in Alliance stock to be released from escrow upon Health Canada ACMPR approval.

Commenting on the acquisition of a Quebec late stage licensed producer applicant, Dennis Petke, Alliance Growers' President and CEO, stated "Management of Alliance Growers continues to carry out our mandate to build a diversified global cannabis company that will be where the market is going, not where the market is today. Alliance Growers is focused on two primary streams in the cannabis space which are the most sustainable and that are here to stay; the grow stream and the medical CBD Oil stream. To optimally drive Alliance Growers growth and stature in the grow space, we have determined that acquiring a Quebec license would be both a key driver to success and a key pillar in Alliance' strategic business plan."

About Alliance Growers
Alliance Growers Corp is a diversified cannabis company driven by the Company's 'Four Pillars' Organization Plan — Cannabis Botany Centre, Strategic ACMPR Investments, CBD Oil Supply and Distribution, and Research and Development.
Alliance Growers has finalized its a new business partnership with WFS Pharmagreen Inc., to jointly develop and operate a 40,000-square foot facility to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in general. The proposed Cannabis Botany Centre will grow Cannabis plantlets using proprietary tissue culture propagation, specifically the "Chibafreen Invitro Plant Production System", which assures consistent composition and purity of each plantlet for the growers.

Further, Alliance Growers has been negotiating to obtain other exclusive Canadian distribution agreements for certain proprietary products for support of the Cannabis growing industry in addition to possible partnerships with Licensed Producer Applicants at various stages in the Health Canada License process.

For further information, please visit the Company's corporate website at www.alliancegrowers.com or the Company's profile at www.sedar.com.
If you would like to be added to Alliance Growers' news distribution list, please send your email address to newsletter@alliancegrowers.com.
On behalf of the board of directors of
ALLIANCE GROWERS CORP.
"Dennis Petke"
Dennis Petke
President and CEO
For more information contact:
Dennis Petke
Tel: 778-331-4266
DennisPetke@alliancegrowers.com
Rob Grace
Communications Consultant
Tel: 778-998-5431
RobDGrace@gmail.com

THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.
FORWARD LOOKING INFORMATION
This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. More particularly and without limitation, the news release contains forward-looking statements and information relating to Company's corporate strategy. The forward-looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company's ability to carry out its business plan. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company's ability to identify and complete additional suitable acquisitions to further the Company's growth as well as risks associated with the medical marijuana industry in general, such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.

Alliance Growers completes Pharmagreen investment

2018-02-07 08:31 ET - News Release

Mr. Dennis Petke reports
ALLIANCE GROWERS COMPLETES STRATEGIC INVESTMENT IN PHARMAGREEN
Alliance Growers Corp. has completed the company's strategic $300,000 investment in Pharmagreen. The equity investment is a private placement in Pharmagreen for a total of $300,000 at a price of 25 cents per share.

Pharmagreen operations will be in British Columbia, Canada, with the construction of the cannabis botany centre as a wholly owned subsidiary of Pharmagreen. In the United States, Pharmagreen currently holds a 100-per-cent interest in Canna Companion Products Inc. Pharmagreen on behalf of BC Newco has commenced multiple applications for Health Canada licences with its consulting group Cannabis Compliance Inc. Alliance Growers as a strategic partner with Pharmagreen is investing $3-million for a 30-per-cent interest in the cannabis botany centre in Mission, B.C., having already made a deposit of $250,000.
The investment is important to Alliance Growers' growth and success for two reasons:

• Accelerates the development of the cannabis botany centre;
• Provides a profitable investment that has near-term liquidity.

Commenting on the strategic investment in Pharmagreen, Dennis Petke, Alliance Growers' president and chief executive officer, noted: "We are very fortunate to be able to strategically invest in Pharmagreen at such a discounted price to the anticipated opening public market price of $1/share. Finalizing the BC Newco investment of $3-million in the cannabis botany centre is the most significant milestone in the company's business plan. Now that Alliance is capitalized, we will be working closely with Pharmagreen to accelerate the development of the cannabis botany centre. It represents the beginning of the execution of multiple initiatives that Alliance Growers has been developing over the last year. Alliance Growers has already acquired interests in two ACMPR applicants, notably Biocannatech, whereby Alliance recently acquired 100-per-cent ownership of this late-stage Quebec ACMPR applicant; and Canwe, a private company based in Ontario that has applied for its ACMPR licence and is currently in the review and security clearance stage. Alliance continues to negotiate further acquisitions in the grow space in Canada and Australia. The company will be executing on additional acquisitions of interests in ACMPR applicants, development of the Canna-App and finalization of its pharmaceutical grade CDB oil partnership with the Israeli Medical Cannabis Company. Alliance Growers intends to live long and prosper by building a global cannabis company for where the market is going."

About Alliance Growers Corp.
Alliance Growers is a diversified cannabis company driven by the company's four-pillar organization plan -- cannabis botany centre, strategic ACMPR (Access to Cannabis for Medical Purposes Regulations) investments, CBD oil supply and distribution, and research and development. Alliance Growers has finalized its new business partnership with WFS Pharmagreen Inc., to jointly develop and operate a 40,000-square-foot facility to be the first of its kind in Western Canada to house a DNA botany lab, extraction facility and tissue culture plantlet production facility to service the cannabis market and agriculture market in general.
We seek Safe Harbor.

Investing in Murky Markets

The chatter recently in the markets is hard to avoid but is it all just chatter? I didn't get on the Bitcoin train and instead picked a few small marijuana start ups at the start of the year with my cash on hand. My long term investments I just left to wash out and will revisit them once all this dust settles. The pot side of the markets can often be blurry and companies don't always look legitimate due to old management still stuck on drill results. Having said that they still want to grow a company and return an investment for investors. Some though are just looking for a grab at that last straw before they find out they have nothing left. I would still rather bet on a pot maybe play than an overbought crypto giant just waiting for a major adjustment. A majority of traders likely scratched their head every morning as Bitcoin kept climbing higher and high and analysts through around lofty projections.

When a market gets ahead of itself it needs to retrace and find it's bottom or floor support. The crypto space even remotely connected to Bitcoin has soured and even the good plays look scary right now. But in reality isn't this what we really need to see? When the analysts all talked about how many Zombie Stocks were polluting the exchange most of us cheered for them to just die off so that investors wouldn't get caught up in the lottery stocks and focus on real deals. It's hard to imagine people would chase lottery plays but millions of dollars every day are spent on lottery type stocks by retail investors all in a hail Mary attempt to recapture losses from other plays. I once read that 90% of new retail investors lose it all in the first year. That sounds staggering but that's because they never looked at the mechanics of investing vs "playing the markets"

A popular trend can only catch fire for so long, then it becomes out of fashion and it's hard to tell what's just a trend and what is being adopted as a new industry standard. A high percentage of investors and brokers thought marijuana investing was just a short lived trend that would likely not survive very long but then it wasn't. It happens that fast. Crypto or blockchain stories are the same in my opinion. Most of us don't really know how they will shape our world or if we will ever notice them in our day to day lives but they are there. Some are just head fakes but some are slowly slipping into every fabric of our routine. One day we will just realize this is the future. In every movement there are pull backs, society is always resistant to change but we have to evolve in a digital world to protect what we have. I don't think we should be so quick to dismiss the growth ahead for crypto stocks. I don't know who the next big winner is but some high flyers will get brought down a notch or two and some emerging players will likely have their day. If you really stop to think about it there are an infinite number of ways algorithmic platforms can save us time, money and give us peace of mind. Most of which have absolutely nothing to do with Bitcoin.

Alliance Growers to buy Biocannatech

Alliance Growers to buy Biocannatech for $600K, shares

2018-01-25 11:06 ET - News Release

Mr. Dennis Petke reports
ALLIANCE GROWERS FINALIZES QUEBEC LATE STAGE ACMPR APPLICANT ACQUISITION
Alliance Growers Corp. has finalized the terms and conditions of the exclusive agreement to acquire a late-stage licensed producer applicant, Biocannatech, to become a licensed producer under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR) in Quebec. Alliance Growers will supply financing and resources to build out the medical marijuana facility in preparation for the inspection required to obtain a growing licence. Once Health Canada is satisfied with a successful crop, Alliance Growers will be granted its distribution license. The terms of the deal call for Alliance Growers to pay staged consideration totalling $600,000 and 7.4 million shares valued at a deemed price of $1 per share, in return for 100 per cent of Biocannatech.

• $100,000 cash plus 1,350,000 shares on signing;
• 1,450,000 shares released immediately at application approved for Ready to Build;
• $500,000 plus 1,200,000 shares paid immediately at permits approved stage;
• 1,700,000 shares released immediately at cultivation stage;
• 1,700,000 shares released immediately at Health Canada ACMPR approval.

The shares will be issued at the closing, and all but 1,350,000 shares will be held in escrow and released in stages following completion of each of these milestones. This is a key acquisition for Alliance Growers and its shareholders, as it integrates various components of its 'Four Pillars' Organization Plan, whereby the Company will become a licensed producer in the province of Quebec, along with the recently announced development of the Cannabis Botany Centre. This move opens access for distribution of tissue culture plantlets, not only to Biocannatech, but potentially to all licensed producers in Quebec. Quebec represents approximately 20% of Canada's population, and the Province is anxious to develop a base of skilled licensed producers to provide a self-sustaining supply for Quebec based demand of both recreational and medical cannabis.

The initial Biocannatech facility is configured at 10,000 sq. ft. and is attached to a 120,000-sq. ft. warehouse to provide for phased expansion. Biocannatech will have the capacity to produce up to 1,000 kg per year initially, and be able increase that output in subsequent phases of expansion. Commenting on finalizing the acquisition of a Quebec late stage licensed producer applicant, Dennis Petke, Alliance Growers' President and CEO, stated "Quebec's ACMPR licenses are currently underrepresented relative to other provinces in Canada. Management of Alliance Growers believes it is advantageous to capitalize on the mandate to increase the number of ACMPR licensed companies in Quebec. We are pleased to have now entered the grow space in Quebec as we negotiate additional license applicants in this province. In addition to growing, we look forward to becoming a preferred tissue cultured plantlet supplier to the Quebec ACMPR community. Today's announcement supports Alliance Growers mandate to build a diversified global cannabis company that will be focused on where the market is going, not where the market is today. "

'Today's bellwether announcement is an important part of Alliance Growers significant growth plans for 2018, as we take the Company to where the industry is going. Alliance Growers is concentrating on two primary streams in the cannabis space which are the most sustainable and that are here to stay; the grow stream and the medical CBD Oil stream. The Company wishes to thank investors for their support and patience as it progresses during this exciting time for the cannabis industry".

About Alliance Growers Corp.

Alliance Growers is a diversified cannabis company driven by the company's four-pillar organization plan -- cannabis botany centre, strategic ACMPR investments, CBD (cannabidiol) oil supply and distribution, and research and development. Alliance Growers has finalized a new business partnership with WFS Pharmagreen to jointly develop and operate a 40,000-square-foot facility to be the first of its kind in Western Canada to house a DNA botany lab, extraction facility and tissue culture plantlet production facility to service the cannabis market and agriculture market in general.

Alliance Growers has entered into an exclusive agreement to acquire a late-stage licensed producer applicant, Biotech Canna, to become a licensed producer under Health Canada's ACMPR in Quebec. Alliance Growers will supply financing and resources to build out the medical marijuana facility in preparation for the inspection required to obtain a growing licence.

We seek Safe Harbor.

GreenPower receives commitments for six EV Star units

2018-01-16 12:43 ET - Shareholders Letter

Mr. Brendan Riley reports
GREENPOWER RELEASES LETTER TO SHAREHOLDERS
GreenPower Motor Company Inc. has released the following open letter to shareholders.
Dear fellow shareholders,
First and foremost, I want to begin by thanking you for your continuing commitment and support as we continue our pursuit of building the North American leader in all-electric bus transportation. Two thousand seventeen was a year of tremendous progress for the industry and our company, and as we drive into 2018, I want to share with you some of the various developments taking place at GreenPower Motor Company. Last year, we launched the world's first purpose-built, battery-electric school bus, the Synapse 72, and received 11 purchase commitments for this model. One of the orders is from the Los Angeles Unified School District, which as a customer by itself could consume all of our manufacturing capacity for the next few years if we were to replace only a small part of their fleet. Deliveries for this model will start in June, 2018. Currently, five units are in production, and all 11 buses are expected to be delivered by the end of 2018.

Another key milestone involves the demonstration of our EV550 double-decker that has been running in Victoria, B.C., with CVS Tours. This initial one-bus, one-year demo lease has turned into a commitment for nine buses, representing 100 per cent of CVS's double-decker fleet. CVS is our first repeat customer, and also the first entity in North America to acquire what happens to be the only all-electric, purpose-built double-decker bus in the market. Two of the nine units are already built and will be running by March of this year. The remaining seven will be delivered by 2020. We continue to market our double decker both in Canada and United States, and this product alone has tremendous potential for our company.

In California, deliveries have commenced for the heart of our transit line, the EV350 (our 40-foot low-floor transit bus), to Porterville Transit. We expect the first of these buses to enter service in March, 2018, and expect all 10 to be in full service by end of this summer.
The Synapse shuttle, which is based on our school bus design, is also generating significant interest in the market. This bus has been on demonstration tours in both the U.S. and Canada, and we are confident that initial sales will be achieved in the coming quarters.

I am excited to introduce to you our 25-foot, Class 4 mini-bus: the EV Star. This new model will officially be on the market in April of 2018. We have 10 units currently in production, scheduled for May completion, and already have commitments for six of these units. An aggressive schedule of demonstrations is set for this summer, and in terms of unit sales, this product could very well emerge as our No. 1 seller. New in 2017, our EV250 30-foot, low-floor transit bus was unveiled at the National APTA show in Atlanta this past October and has received multiple requests for demos and quotes. Since then, the bus has gone on demonstrations in Arizona and throughout California. As we continue to market this bus along with our entire product offering, our pipeline is building, and long sales cycle decisions become increasingly probable, supporting our overall outlook. We are committed to achieving initial sales of EV250 this year.

Construction for our Porterville assembly plant continues, and this month we are opening a new Los Angeles sales office. We have hired a vice-president of school bus sales and marketing, Ryne Shetterly. Mr. Shetterly comes to us with more than 10 years of experience in the manufacturing and sales of heavy-duty vehicles. Most recently, he ran sales for Complete Coachworks selling its commercially successful ZEPS, heavy-duty battery electric buses. We are currently in the process of hiring sales, engineering, administrative, maintenance and production staff to support our sales activities, as well as process and build our orders, and to maintenance our deployed equipment.
All of our models have been approved by CARB for HVIP vouchers; providing a minimum of $90,000 per EV Star and up to $245,000 for the Synapse 72. Every one of our models has been certified by the U.S. EPA, the first hurdle for making them eligible for many national and local incentives. Our EV550 double-decker is already eligible for vouchers in B.C. that our customer CVS Tours is using for its purchase. Our school bus, the Synapse 72, will actually cost less than the equivalent diesel school bus with the California HVIP voucher. This means we ultimately provide a school bus that is safer, costs less to buy and costs less to operate in perpetuity. All this while cleaning the air and protecting the environment.
The GreenPower advantages are:

• The only zero-emission product line that addresses transit, school and private operator markets. We are the only public small cap pure play, with a full product offering being marketed in North America, and as a result, we are emerging as a significant player in the industry.
• Our management team has a proven record of designing, building and selling new energy vehicles.
• The lowest per seated passenger price of any heavy-duty EV product.
• We utilize and leverage the current charging infrastructure that is already in place and is in the process of doubling (thanks in part to VW settlement moneys).
• GreenPower has clean-sheet bus designs that use the best components available on the market today.
• We have a very robust sales pipeline and are building and delivering product.
• We are working on developing our next-generation products like solid state batteries and autonomous vehicles, which we'll discuss in further detail in future updates.
• Importantly, customers that have demonstrated our buses are placing orders for more, a true and vital vote of confidence.

With all of our accomplishments, we need to amplify our message. We expect to hire a PR firm and engage a seasoned professional for a direct campaign to secure new shareholders. With the breadth and quality of our product offering, the team we have assembled, our sales successes to date, and our ever-growing sales pipeline, we are more confident than ever that our years ahead show promise. While our stock performance languished throughout 2017, our team never wavered and we achieved corporate milestones vital to our success!

As we continue to build this company, sooner or later I sincerely believe the market will appreciate what we have built, and the rightful value of our product, and the opportunity we have in front of us.
I would like to thank you, our shareholders, our employees and our customers for your past and continued support in helping us bring these clean air products to market. Together, we will continue provide compelling solutions for the most seminal issues of our time. Our future is green!
Wishing you all a prosperous new year!

About GreenPower Motor Company Inc.
GreenPower Motor Company develops electric powered vehicles for commercial markets. GreenPower offers a range of electric-powered buses deploying electric drive and battery technologies with a lightweight chassis and low-floor or high-floor body. GreenPower's bus is based on a flexible clean sheet design and utilizes a custom battery management system and a proprietary Flex Power system for the drive motors. GreenPower integrates global suppliers for key components such as Siemens for the two drive motors, Knorr for the brakes, ZF for the axles, and Parker for the dash and control systems.
We seek Safe Harbor.

Blockchain Simplified by Data Deposit Box

Data Deposit releases hybrid blockchain as a service

2018-01-08 15:47 ET - News Release

Mr. Tim Jewell reports
DATA DEPOSIT BOX RELEASES CLOUD PLATFORM VERSION 2018; HYBRID BLOCKCHAIN AS A SERVICE
Data Deposit Box Inc. has released its cloud platform version 2018. The new platform includes the release of hybrid blockchain as a service. The service will support the growing number of distributed ledger technologies plus enable deployment of private blockchains for multi-vendor business networks.

The massive growth in public blockchain development has exposed some fundamental weaknesses, most notably scalability and performance. The requirement to integrate blockchain technology into multi-vendor business networks is driving the need for hybrid and private blockchains. The Data Deposit Box platform supports massive scalability, redundancy, governance and audit capabilities, which work alongside our eventual consistency technology to ensure data integrity at any point in time throughout the chain. Data Deposit Box's depth of experience with big-data for the last 15 years has positioned the company very well to expand into the Hybrid Blockchain industry. Our platform simplifies the development and integration required to implement blockchain technology into a business process and virtually eliminates management normally required at such massive scale.

At the core of blockchain is data integrity. Regulatory challenges like Legal Hold (SEC 17-4), immutable objects, life-points, WORM (SEC 17a4), non-erasable and Content Integrity Seals are built into the core product and have matured over years of development. Management challenges like single points of failure, expanding capacity and rolling upgrades without downtime have also been hardened over years. Erasure encoding set at the block level allows your business to design your desired level of data durability and service level agreements. Patented technology lets you prove in a court of law that content has not been tampered with. Large Enterprises and multi-vendor business networks can now deploy private or hybrid blockchain implementations to isolate their business networks from the challenges faced by public blockchains.

The Data Deposit Box platform offers a single interface to work with public and private implementations. Said Tim Jewell, CEO of Data Deposit Box: "The Data Deposit Box platform is multi-tenant and can be used by companies building blockchain into the business process. We are in discussions with both large enterprise and the banking sector to implement the platform."

ABOUT DATA DEPOSIT BOX:
Providing advanced, cloud-based data back-up since 2002, Data Deposit Box is one of the world's first and foremost data backup, protection and recovery providers for Managed Service Providers (MSPs), as well as Small and Medium Businesses (SMBs). Data Deposit Box offers full white labeling for larger MSPs. Based in Toronto, Canada, Data Deposit Box is trusted by over 5,000 MSPs, SMBs and personal end-users world-wide to make data back up as simple and smart as possible.

Data Deposit Box has refactored components of its existing cloud platform to develop products for the Blockchain industry.
We seek Safe Harbor.

THREED CAPITAL TEAMS UP WITH ST-GEORGES

ThreeD, St-Georges partner on $20M debenture offering

2018-01-08 07:06 ET - News Release

Mr. Sheldon Inwentash reports
THREED CAPITAL TEAMS UP WITH ST-GEORGES ECO-MINING ON $20M DEBENTURE OFFERING FOR SUBSIDIARY ZEU CRYPTO NETWORKS
ThreeD Capital Inc. has teamed up with St-Georges Eco-Mining Corp. to introduce ZeU Crypto Networks to its global network and blockchain ecosystem. St-Georges has announced that its wholly owned subsidiary, ZeU Crypto Networks Inc., a private blockchain technology company, intends to sell $20-million aggregate principal amount of 10.00 per cent convertible unsecured debentures on a non-brokered offering basis.

Sheldon Inwentash, chairman and chief executive officer of ThreeD Capital, stated: "ThreeD Capital, through its wholly owned subsidiary, Blockamoto.io, has set a mandate to provide strategic advice to assist early-stage blockchain solutions in reaching viability as quickly as possible. ZeU Crypto Networks could represent the most disruptive protocol of the already disruptive blockchain industry." Blockchain and smart contract technology licence

On Jan. 4, 2018, St-Georges announced the signing of a significant, non-arm's-length blockchain and smart contract technology licence agreement, with Qingdao Tiande Technologies Inc. St-Georges immediately assigned the licence to its newly formed wholly owned subsidiary, ZeU Crypto Networks Inc. Tiande is led by world-renowned blockchain expert, Dr. Wei-Tek Tsai, who initiated the first academic laboratory dedicated to blockchain research and education in China at Beihang University's School of Computer Science and Engineering.

Dr. Tsai received his SB in computer science and engineering from Massachusetts Institute of Technology (MIT) at Cambridge, Mass., in 1979, MS and PhD in computer science from University of California at Berkeley in 1982 and 1985. He joined Arizona State University, Tempe, Ariz., in 2000 as a full professor of computer science and engineering in the school of computing, informatics and decision systems engineering. He became an emeritus professor in December, 2014. He has authored more than 500 papers in software engineering, service-oriented computing, cloud computing and blockchains. He travels widely and has held various professorships in Asia and Europe.

About ThreeD Capital Inc.
ThreeD is a publicly traded Canada-based venture capital firm focused on opportunistic investments in companies in the junior resources, artificial intelligence and blockchain sectors. ThreeD seeks to invest in early-stage, promising companies where it may be the lead investor and can additionally provide investees with advisory services, mentoring and access to the company's network in order to earn increases to the company's equity stake.

© 2018 Canjex Publishing Ltd. All rights reserved.

Data Deposit Box secures patent in blockchain space

Data Deposit Box receives Canadian patent

2018-01-03 11:52 ET - News Release

Mr. Tim Jewell reports
DATA DEPOSIT BOX ENTERS BLOCKCHAIN INDUSTRY WITH NEWLY AWARDED PATENT
Data Deposit Box Inc. has been awarded Canadian patent No. 2,718,274. This patent, in addition to U.S. patent No. 8,843,639, enables Data Deposit Box to expand its product offerings to aggressively enter the blockchain industry. This patent is critical to the company's platform and uniquely positions the company to deliver patent-protected solutions.
The company is on track with new products planned for general availability in Q1 2018.

About Data Deposit Box Inc.
Providing advanced, cloud-based data backup since 2002, Data Deposit Box is one of the world's first and foremost data backup, protection and recovery providers for managed service providers (MSPs) as well as small and medium businesses (SMBs).

Data Deposit Box is using components of its existing robust platform to develop products for the blockchain industry.

Alliance Growers to acquire Quebec ACMPR applicant

2018-01-02 06:24 ET - News Release

Mr. Dennis Petke reports
ALLIANCE GROWERS TO ACQUIRE QUEBEC LATE STAGE ACMPR APPLICANT
Alliance Growers Corp. has entered into an exclusive agreement to acquire a late-stage licensed producer applicant, Biotech Canna, to become a licensed producer under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR) in Quebec. Alliance Growers will supply financing and resources to build out the medical marijuana facility in preparation for the inspection required to obtain a growing licence. Once Health Canada is satisfied with a successful crop, Alliance Growers will be granted its distribution licence. This is a key acquisition for Alliance Growers and its shareholders, as it allows the company an opportunity to become a licensed producer in the province of Quebec and gain an in-road to provide tissue culture plantlets to all licensed producers in Quebec.
There are several key points of value that are unique and advantageous to a Quebec licence that include:

• Twenty per cent of Canada population is in Quebec.
• Only two licences have been approved in Quebec with only one producing (Hydropocathary).
• The Quebec government has always looked to attain 25 per cent of whatever Canada's intentions are with business. It has publicly stated it wants Health Canada to process all the licences -- 16 applications -- in Quebec and have the applications approved swiftly.
• Quebec will only purchase the supply from Quebec growers, it will not go outside to other provinces for supply if it does not need to. The initial Biotech Canna facility is 10,000 square feet and is attached to a 120,000 square ft warehouse for expansion. Biotech Canna will produce up to 1,000 kilograms per year and will increase that output in phase 2 of expansion.

Alliance Growers is making an initial payment of $100,000 and $150,000 in stock. Alliance Growers will acquire 100 per cent of the Quebec late-stage licensed producer applicant in stages for a total consideration of $8-million -- cash consideration of $600,000 and $7.4-million in stock at a deemed value of $1/share, the final payment of $500,000 in Alliance stock to be released from escrow upon Health Canada ACMPR approval.

Commenting on the acquisition of a Quebec late-stage licensed producer applicant, Dennis Petke, Alliance Growers' president and chief executive officer, stated: "Management of Alliance Growers continues to carry out our mandate to build a diversified global cannabis company that will be where the market is going, not where the market is today. Alliance Growers is focused on two primary streams in the cannabis space which are the most sustainable and that are here to stay: the grow stream and the medical CBD oil stream. To optimally drive Alliance Growers growth and stature in the grow space, we have determined that acquiring a Quebec licence would be both a key driver to success and a key pillar in Alliance's strategic business plan."

About Alliance Growers Corp.
Alliance Growers is a diversified cannabis company driven by the company's four pillars organization plan -- cannabis botany centre, strategic ACMPR investments, CBD oil supply and distribution, and research and development.

Alliance Growers has finalized its a new business partnership with WFS Pharmagreen Inc., to jointly develop and operate a 40,000-square-foot facility to be the first of its kind in Western Canada to house a DNA botany lab, extraction facility and tissue culture plantlet production facility to service the cannabis market and agriculture market in general.
We seek Safe Harbor.

Alliance Growers to acquire 15% of Pharma subsidiary

2017-12-28 11:29 ET - News Release

Mr. Dennis Petke reports
ALLIANCE ENTERS INTO BINDING LETTER OF INTENT WITH WFS PHARMAGREEN FOR DEVLOPMENT OF THE BOTANY CENTRE
Alliance Growers Corp. has entered into a binding letter of intent with WFS Pharmagreen Inc. and its proposed subsidiary BC New Co., to create a strategic relationship, together with equity participation by Alliance Growers and Pharmagreen, whereby Alliance Growers will acquire an equity interest in Pharmagreen's subsidiary B.C. New Co.

The execution of this LOI, to be followed by a formal definitive agreement, initiates the development of the Cannabis Botany Centre that Alliance and Pharmagreen have been working on for over one year. Pharmagreen principals have purchased the land required to build the Cannabis Botany Centre, east of Mission, B.C. The land will be leased to own to B.C. New Co.

Alliance Growers will purchase B.C. New Co. shares equal to 15 per cent of the issued B.C. New Co. shares for total consideration of $1.5-million by March 15, 2018. Alliance Growers will have an option to increase its non-dilutive interest in B.C. New Co. to 30 per cent by the investment of a further $1.5-million by June 15, 2018. Alliance Growers made an initial payment of $250,000 toward the first obligation on Dec. 21, 2017. Alliance Growers will elect one of the three Directors of B.C. New Co., which will build and operate the Cannabis Botany Centre to permit the growth and sale of tissue culture plantlets, and storage of strains and nursery plants to wholesale, retail, and medical markets.

The development of the Cannabis Botany Centre is consistent with Alliance Growers business plan to be in partnership with a range of cannabis sector business opportunities including strategic investments in Access to Cannabis for Medical Purposes Regulations-licensed cannabis producers. Alliance Growers has already acquired interests in two ACMPR applicants, most notably Canwe, a private company based in Ontario that has applied for its ACMPR licence and is currently in the review and security clearance stage.

Commenting on the development of the Cannabis Botany Centre, Dennis Petke, Alliance Growers's president and chief executive officer, noted: "We are very fortunate to be able to commence construction as soon as reasonably possible, rather than having to wait several months under the typical ACMPR application scenario. This shortens our timeline to receive approval for an ACMPR application.

"Finalizing the Pharmagreen deal is one of the most significant milestones in the company's business plan. It represents the beginning of the execution of multiple initiatives that Alliance Growers has been developing over the last year. Now that Alliance Growers has secured funding of over $1-million from the recent private placement and the exercise of warrants and options, the company will be executing on additional acquisitions of interests in ACMPR applicants, development of the Canna-App and finalization of its pharmaceutical-grade CDB Oil partnership with the Israeli Medical Cannabis Company. We are extremely pleased that the market has come to understand and appreciate our diversified global business model as evidenced by the strong performance in the company's recent stock price. The company has already received significant interest in additional financings slated for January and February of 2018 to ensure the company is adequately capitalized to execute on all aspects of our business model. All stakeholders of Alliance Growers will benefit from the arrangements we are making in the cannabis cultivator space. We look forward to announcing our new complementary acquisitions and as we move forward. Alliance Growers wishes everyone a happy, healthy and prosperous new year."

About Alliance Growers Corp.
Alliance Growers is a diversified cannabis company driven by the company's four-pillar organization plan: cannabis botany centre, strategic ACMPR (Access to Cannabis for Medical Purposes Regulations) investments, CBD (cannabidiol) oil supply and distribution, and research and development. Alliance Growers has executed an agreement with Botanical Research In Motion International Inc. for a Canada exclusive licence to jointly develop and operate a 40,000-square-foot facility to be the first of its kind in Western Canada to house a DNA botany lab, extraction facility and tissue culture plantlet production facility to service the cannabis market and agriculture market in general.

Alliance Growers has rights to 50 per cent of BCMM, a late-stage applicant that submitted its ACMPR application to Health Canada in 2014, and is also making a strategic investment in another private company preparing to apply for an ACMPR producer licence.
We seek Safe Harbor.

Quadron completes sale of Boss CO2 extraction unit

2017-12-21 10:51 ET - News Release

Ms. Rosy Mondin reports
QUADRON CANNATECH SECURES ADDITIONAL SALE OF THE BOSS CO2 EXTRACTION SYSTEM
Quadron Cannatech Corp. has completed another sale of the Boss CO2 (carbon dioxide) extraction system to an authorized cannabis industry participant located in Fraser Valley, B.C. "Over the extensive development phase of the next generation CO2 Extraction System {A –} the "BOSS", our team of engineers engaged with a broad base of industry participants and listened to their needs to better understand the task at hand. The results are simply amazing {A –} visitors lined up at our booth to talk with our representatives at the recent MJBiz Conference in Vegas where we showcased the BOSS," stated Rosy Mondin, CEO & President of Quadron. "There is an immediate need for innovation, automation, analytics, and predictable recoveries in cannabis extraction. The BOSS is a revolutionary system that will no doubt disrupt the industry and build a new, worldwide benchmark for extraction technology, and industry standards moving forward."
Quadron is ramping up production of its BOSS CO2 Extraction Systems in anticipation of completing additional orders as interested buyers conclude their investigation and analysis of available CO2 extraction systems on the market. Sales of the BOSS is expected to be a significant revenue growth driver for Quadron in 2018 and beyond.

The BOSS CO2 Extraction System combines proprietary max flow technology with advanced thermodynamics, automated features and an exclusive plug and play design. The BOSS has a very small footprint, requiring only a fraction of the space and energy requirements compared to other systems on the market. Installation is simple {A –} no external hardware or facility renovations required. All that is needed are two electrical outlets and an hour to set-up.
THE BOSS EXTRACTION SYSTEM ADVANTAGES

• Automated system with remote monitoring and control features
• Software collects, stores, and analyzes data for Research & Development
• Programmable cycles - maximizing extraction and separation efficiency
• Plug and Play self-contained system with no external setup required
• Simplified assembly with only two pieces of equipment to set-up, two plugs and four hoses to connect
• Integrated heat exchanger with proprietary advanced thermodynamics
• High precision operating parameters for accurate performance
• Ability to collect extract during runtime

According to a Mackie Research Capital Corp. report, which assumes full legalization (medical and recreational) in 2018, the growth of cannabis oil consumption in Canada is expected to grow from 284 litres in 2015 to 562,613 litres by 2020 (198,000-per-cent growth) versus dried marijuana consumption of 6,388 kilograms in 2015 to 110,034 kilograms in 2020 (1,600-per-cent growth).
About Quadron Cannatech Corp.
Quadron focuses on ancillary equipment, products and services for the authorized cannabis industry, providing automated extraction and processing solutions, and sales of end user delivery solutions such as vape pens, capsules and other safer consumption solutions for patients.
We seek Safe Harbor.

East Asia drilling

East Asia continues drilling at Sangihe

2017-12-13 14:02 ET - News Release

Mr. Terry Filbert reports
EAST ASIA PROVIDES UPDATE ON DRILLING PROGRESS FOR INDONESIAN GOLD PROPERTY
East Asia Minerals Corp. has released an update on current exploration activities relating to the continuing Indonesian feasibility study (IFS), AMDAL environmental report status, geotechnical and metallurgical work being conducted at its Sangihe gold property in Indonesia.

The company's focus is on completing the Indonesian feasibility study (IFS) and AMDAL environmental reports as once they are submitted and accepted by the Indonesian Mining Department (MEMR), construction of the mining facilities and infrastructure can begin at the Sangihe project. The company anticipates making a decision for gold processing and production to begin by mid 2018. The Indonesian feasibility study is not a feasibility study as defined by Canadian Institute of Mining as required by National Instrument 43-101 but is required under Indonesian law in order to obtain a licence to construct a production facility. The company cautions readers that the any production decision made by the company will not be based on an NI 43-101 feasibility study of mineral reserves that demonstrates economic and technical viability and as such, there may be increased uncertainty and various technological and economic risks.

The IFS, which is being conducted by Resindo Resources and Energy, an Indonesian consulting firm, is well under way and comprised of several elements. Metallurgical drilling of three twin holes has been completed during the month of October. These holes identify the most suitable heap-leaching locations. Samples obtained are currently undergoing metallurgic bottle-roll testwork at Geoservices Laboratory. Cyanide-soluble assay results received for the metallurgy samples submitted showed gold recoveries of 85 per cent and silver recoveries of 96 per cent.

Drilling of six geotechnical holes has commenced with hole number three in progress. This drilling is a required component for Indonesian feasibility study (IFS) in order to provide the most up to date and accurate core samples for pit-wall design. Hydro-geological surveying is complete and is designed to help locate and identify the water table level in the pit design and best water sources needed for upcoming drilling, heap-leaching and ultimately gold production.

The company is very pleased with the drilling progress considering the weather conditions have been less than favourable. The monsoon season started earlier than normal this year, making the drilling process difficult which could ultimately delay the final AMDAL and IFS reports by a few weeks. Overall site layout including the location of heap-leach pads, processing plant and waste-dump areas has been completed. The overall site layout was designed to be very concise and therefore has a total footprint area of 42 hectares which is 0.1 per cent of the 42,000 hectares Sangihe gold property total area.

Frank Rocca, BAppSc (geology), MAusIMM, chief geologist of East Asia Minerals, is the qualified person as defined under NI 43-101 who has reviewed and approves the content of this release.
Sangihe project

The Sangihe gold-copper project is located on the island of Sangihe off the northern coast of Sulawesi and has an existing National Instrument 43-101 inferred mineral resource of 114,700 indicated ounces and 105,000 inferred ounces of gold. The company's 70-per-cent interest in the Sangihe mineral tenement contract of work is held through PT Tambang Mas Sangihe. The remaining 30-per-cent interest in PTTMS is held by three unaffiliated Indonesian corporations. The term of the Sangihe CoW agreement is for 30 years upon commencement of the production phase of the project.
We seek Safe Harbor.

EXCLUSIVE TECHNOLOGY LICENSING AGREEMENT

St-Georges, Iconic sign technology licensing agreement

2017-12-07 14:18 ET - News Release
Also News Release (C-ICM) Iconic Minerals Ltd (2)
Mr. Frank Dumas reports
EXCLUSIVE TECHNOLOGY LICENSING AGREEMENT WITH ICONIC MINERALS FOR NEVADA OPERATIONS
St-Georges Platinum and Base Metals Ltd. and Iconic Minerals Ltd. have entered into a definitive exclusive technology licensing agreement for all sites to be operated by Iconic and/or its affiliates in the state of Nevada.
In return for a perpetual licence for the technologies and its future improvements, Iconic will pay to St-Georges:

• Invest by way of private placement CAD $100,000 in St-Georges equity within 6 months.
• Issue in total 5 million common shares of Iconic to be released in stages, based on benchmarks reached. The performance schedule outlining the stages of each development phase where shares will be issued according to the schedule below:
  • 2,000,000 shares at Stage 1 Benchmark completion: which is defined by the delivery of a viable lithium recovery positive independent laboratory currently commissioned to by St-Georges;
  • 1,500,000 shares at Stage 2 Benchmark completion: which is defined by independent report describing results of initial pilot mining operations and the processing of a minimum of one (1) metric ton in a simulated industrial environment; and
  • 1,500,000 shares at Stage 3 Benchmark completion: which is defined by the reception of a Preliminary Economical Assessment Report (PEA) or at commercialization decision or the third (3 rd ) year anniversary mark of this agreement assuming other issuance have all been done;
• The shares St-Georges earn in each stage will be escrowed for the duration of 36 months.
• A perpetual Net Revenue Interest Royalty (NRI) of 5% on all minerals produced on sites licensed with SX technologies;

SX Lithium recovery for Clays and Hard Rock Technology
SX technology process lithium bearing material in three (3) phases:

1. It concentrates the lithium bearing material.
2. It converts the lithium to a salt and purifies it through lithium selection. The process involves gasification to activate the lithium and selectively removing the lithium salt from the other elements with the usage of a proprietary technique, which will be kept confidential at this stage.
3. It involves purification and direct production of lithium carbonate or lithium hydroxide and can be linked to a lithium metal production.

"(...) the on-going efforts to develop an in-situ metals recovery technology for geothermal clay related sources in Iceland have allowed the company to explore other potential applications like the one brought to us by Iconic on their Bonnie Claire project in Nevada. We are excited to test other potential applications that includes but is not limited to our other hard rock lithium projects in Quebec", commented Enrico Di Cesare, St-Georges Director and Research & Development Vice-president. "(...) the management relies on its collective experience at developing technology initiatives and is trying to balance transparency disclosure of its progress with the need to protect the intellectual property being generated. We believe that the only way to disclose our results is to put them in the context of their economic viability. This will call for an higher level of independent review and explain or restrain in divulging recuperation rates that means nothing on their own. The 98%+ lithium recovery rate experienced on Bonnie Claire means nothing on its own if there is no scalable economic method attached to it" commented Frank Dumas, St-Georges' CEO & President.

About St-Georges Platinum and Base Metals Ltd.
St-Georges is developing new technologies to solve the biggest environmental problems in the mining industry.

The company controls, directly or indirectly, all of the active mineral tenures in Iceland. It also explores for nickel on the Julie nickel project, for industrial minerals on Quebec's North Shore, and for lithium and rare metals in Northern Quebec and in the Abitibi area. © 2017 Canjex Publishing Ltd. All rights reserved.

Micron Waste to develop cannabis waste digester

2017-12-07 10:20 ET - News Release

Mr. Rav Mlait reports
MICRON TO DEVELOP ON-SITE CANNABIS WASTE DIGESTERS
Micron Waste Technologies Inc. is taking steps to advance its proprietary technology to treat the organic waste from medical cannabis cultivation on-site and in an environmentally friendly and cost-efficient manner.

Micron will develop an organic waste bioprocessing system targeted specifically toward handling medical cannabis organic waste materials, including leaves, twigs and stalks. The company is testing a new type of nanocrystal that would be used in its proprietary four-cycle filtration process. The nanocrystals are expected to further breakdown medical cannabis organic waste so that it can be turned into gray water and then later into clean water.
Micron's medical cannabis organic waste digester will be developed to handle the following waste from cultivation sites:

• Waste from solid plant material, whether a usable plant trim or flower or unusable plant material, such as stalks, roots or soil;
• Any plant waste or extract that is not being used, because it does not meet quality assurance or has been contaminated in some way that would make it unusable in a safe and medical capacity; and
• Liquids or water that could contaminate ground water due to pesticide use.

Cannabis plant waste management practices
Whether professional growers are producing dried buds or collecting resin for extraction, the steps of harvesting and processing creates by-products and waste that must be disposed of according to all applicable regulations. Growers must be aware of and comply with the comprehensive regulatory scheme enacted by governing bodies to ensure that environmental protections and safety are in place.
Proper waste disposal regulations apply whether the grow operation is a caregiver for a few patients or a large-scale facility that supplies dispensaries. The legal responsibility is on growers to ensure proper disposal.

Waste disposal regulations have been slowly adopted and are being constantly updated through piecemeal legislation. This complex legal framework makes any generalizations about disposal requirements for growers difficult, because compliance must be followed on a federal, provincial/state and municipal level, and it varies widely.

"This is a valuable opportunity to bring together research and development efforts from both Micron Waste and our development partners to deliver an urgently needed organic waste treatment system for the medical cannabis cultivation industry that meets Health Canada Cannabis Waste disposal requirements," said Dr. Bharat Bhushan, Chief Technology Officer of Micron Waste.

About Micron Waste Technologies Inc.
Micron Waste Technologies is a well-financed technology company. The company's food and other organic waste system is designed to manage food and other organic waste on-site, converting it into clean water.
We seek Safe Harbor.

Canada Jetlines press conference

Canada Jetlines to hold press conference on Dec. 5

2017-12-04 14:04 ET - News Release

Mr. Mark Morabito reports
PRESS & MEDIA ADVISORY: CANADA JETLINES TO HOST HALIFAX PRESS CONFERENCE
Stan Gadek, chief executive officer of Canada Jetlines Ltd., will be making a key announcement that underpins the company's plans to launch operations in 2018.
The event will take place in the observation deck at the Halifax Stanfield International Airport on Tuesday, Dec. 5, 2017, at 10 a.m. Atlantic Time (9 a.m. Eastern Time).
Location:  observation deck, 1 Bell Blvd, in Enfield, Halifax, N.S.

Media contact:  Jennifer Paterson, director of corporate development, jennifer.paterson@jetline.ca
Halifax International Airport authority contact:  Carole Rankin, carole.rankin@hiaa.ca, mobile at 902-221-4994, telephone at 902-873-6528

About Canada Jetlines Ltd.
Canada Jetlines is set to become Canada's first ultralow-cost carrier airline, with plans to operate flights across Canada, and provide non-stop service from Canada to the United States, Mexico and the Caribbean. Canada Jetlines is led by a board and management team with extensive experience and expertise in low-cost airlines, start-ups and capital markets. The company was granted an unprecedented exemption from the government of Canada that will permit it to conduct domestic air services while having up to 49-per-cent foreign voting interests.
We seek Safe Harbor.

Mazarin, Asbestos Corp. enter partnership with KSM

2017-12-04 11:52 ET - News Release

Also News Release (C-AB) Asbestos Corp Ltd
Mr. John LeBoutillier reports
MAZARIN INC. AND SUBSIDIARY ASBESTOS CORPORATION LIMITED ANNOUNCE A PARTNERSHIP WITH KSM INC.
Mazarin Inc. and subsidiary Asbestos Corp. Ltd. have entered into a partnership with KSM Inc. Under the terms of the agreement by which Asbestos Corp. becomes a shareholder of KSM and the latter will have access to certain metals contained in the chrysotile tailings.

A newly formed company based in Thetford Mines, KSM is focusing its efforts on developing a patented process to produce fertilizers. This new technology was acquired from Dundee Sustainable Technologies in exchange for cash and an ownership stake in KSM and is based on the utilization of low-cost potash, sulphuric acid and metals contained in chrysotile tailings for the production of high-end, sulphate-based fertilizers.

"We are pleased that KSM has obtained a $125,000 grant from the Quebec government as part of a $250,000 financing round," said John LeBoutillier, president of both companies. "These funds will be used by KSM to produce fertilizers at the pilot scale and to perform tests in the field and in greenhouse farms."

GreenPower Motor Company purchase order

GreenPower receives order for electric school bus

2017-12-04 10:44 ET - News Release

Mr. Fraser Atkinson reports
GREENPOWER RECEIVES ORDER FOR L.A. UNIFIED'S FIRST ELECTRIC SCHOOL BUS
GreenPower Motor Company Inc. has received a purchase order and the initial deposit for its Synapse 72 all-electric school bus for the Los Angeles Unified School District.

L.A. Unified is the largest school district in California and second largest in the nation, enrolling more than 640,000 students from kindergarten through 12th grade at more than 900 schools, including 187 public charter schools. L.A. Unified Transportation operates a fleet of approximately 1,300 school buses and transports 41,000 students to and from school each day. Through several grant awards from the South Coast Air Quality Management District, L.A. Unified has been able to replace more than 50 per cent of its diesel engine school buses with 529 compressed natural gas, 100 ultra-low emission, 141 propane, and now, a zero-emission, electric school bus from GreenPower Motor Company.

"We are thrilled to have secured this purchase with L.A. Unified, the largest school bus operator within the state of California," said GreenPower's president, Brendan Riley. "This order represents not just the first electric school bus for the district, but also the start of what we believe will facilitate further electrification of their fleet in the future. We are proud to be working with a leader like L.A. Unified and are incredibly supportive of the school district's overall initiative to promote sustainability and reduce student exposure to harmful emissions."

About GreenPower Motor Company Inc.
GreenPower Motor Company develops electric powered vehicles for commercial markets. GreenPower offers a range of electric powered buses deploying electric drive and battery technologies with a lightweight chassis and low floor or high floor body. GreenPower's bus is based on a flexible clean sheet design and utilizes a custom battery management system and a proprietary Flex Power system for the drive motors. GreenPower integrates global suppliers for key components such as Siemens for the two drive motors, Knorr for the brakes, ZF for the axles and Parker for the dash and control systems. This OEM platform allows GreenPower to meet the specifications of various operators while providing standard parts for ease of maintenance and accessibility for warranty requirements. For further information go to www.greenpowerbus.com.
We seek Safe Harbor.

Alliance Growers grants options

Alliance Growers grants options to buy 650,000 shares

2017-12-01 06:25 ET - News Release

Mr. Dennis Petke reports
ALLIANCE GROWERS GRANTS STOCK OPTIONS
Alliance Growers Corp.'s board of directors has approved the grant of 650,000 options to directors, officers and consultants of the company, which options are exercisable into common shares of the company at a price of 20 cents per share. Subject to the rules of the Canadian Securities Exchange and the company's stock option plan, the options have a term of five years and will expire on Nov. 30, 2022. At the time of the grant the prior day's closing price of Alliance common shares was 20 cents.

About Alliance Growers Corp.
Alliance Growers is a diversified cannabis company driven by the company's four pillars organization plan -- cannabis botany centre, strategic ACMPR (Access to Cannabis for Medical Purposes Regulations) investments, CBD (cannabidiol) oil supply and distribution, and research and development.